Landing Med has been honored by Forbes China as a "2024 Top Innovative Comprehensive Healthcare Company", a prestigious recognition of its transformative contributions to the healthcare sector. The accolade underscores Landing Med's pioneering leadership in scalable, AI-powered cervical cytology solutions, which have significantly improved access to quality cervical cancer screening for over 11 million women, especially in underserved regions.

图片1

Additionally, Dr. Xiaorong Sun, Founder and Chairwoman of Landing Med, was named a "Person of Influence in the Comprehensive Health Industry" by Forbes China. This distinction highlights her visionary leadership and profound impact on advancing healthcare innovation to address critical women’s public health challenges.

图片2

"As the only pathology company featured on Forbes' 2024 Comprehensive Health List, we are proud of the impact we've made in resource-limited settings," said Lan Wang, Head of Global Marketing at Landing Med. "With the help of AI, digital cytology is now scalable and efficient, ensuring that patients in rural areas receive the same high-quality screening services available in major cities."

These recognitions affirm Landing Med's technological advancements and its unwavering commitment to societal impact. By enabling equitable access to critical healthcare services, particularly in regions with limited pathology resources, the company continues to transform healthcare accessibility and quality through collaborative efforts with its dedicated team and partners.